Mesoblast Ltd. (MESO)
14.87
+0.46
(+3.19%)
USD |
NASDAQ |
Sep 17, 16:00
14.58
-0.29
(-1.95%)
After-Hours: 20:00
Mesoblast Market Cap : 1.928B for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 1.928B |
| September 16, 2026 | 1.868B |
| September 15, 2026 | 1.911B |
| September 14, 2026 | 1.948B |
| September 11, 2026 | 2.007B |
| September 10, 2026 | 2.010B |
| September 09, 2026 | 2.093B |
| September 08, 2026 | 2.125B |
| September 04, 2026 | 2.246B |
| September 03, 2026 | 2.222B |
| September 02, 2026 | 2.242B |
| September 01, 2026 | 2.139B |
| August 31, 2026 | 2.173B |
| August 28, 2026 | 2.261B |
| August 27, 2026 | 2.357B |
| August 26, 2026 | 2.184B |
| August 25, 2026 | 2.229B |
| August 24, 2026 | 2.158B |
| August 21, 2026 | 2.190B |
| August 20, 2026 | 2.246B |
| August 19, 2026 | 2.207B |
| August 18, 2026 | 2.148B |
| August 17, 2026 | 2.193B |
| August 14, 2026 | 2.009B |
| August 13, 2026 | 2.125B |
| Date | Value |
|---|---|
| August 12, 2026 | 2.162B |
| August 11, 2026 | 2.180B |
| August 10, 2026 | 2.149B |
| August 07, 2026 | 2.054B |
| August 06, 2026 | 2.013B |
| August 05, 2026 | 1.928B |
| August 04, 2026 | 1.907B |
| August 03, 2026 | 1.864B |
| July 31, 2026 | 1.826B |
| July 30, 2026 | 1.875B |
| July 29, 2026 | 1.821B |
| July 28, 2026 | 1.862B |
| July 27, 2026 | 1.876B |
| July 24, 2026 | 1.973B |
| July 23, 2026 | 2.072B |
| July 22, 2026 | 2.100B |
| July 21, 2026 | 2.116B |
| July 20, 2026 | 2.143B |
| July 17, 2026 | 2.232B |
| July 16, 2026 | 2.301B |
| July 15, 2026 | 2.350B |
| July 14, 2026 | 2.157B |
| July 13, 2026 | 2.090B |
| July 10, 2026 | 1.989B |
| July 09, 2026 | 1.911B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immutep Ltd. | 46.70M |
| CSL Ltd. | 60.78B |
| Ceryvyn Therapeutics Ltd. | 3.967M |
| Propanc Biopharma, Inc. | 0.5509M |
| Actinogen Medical Ltd. | 115.59M |
Market Cap Related Metrics
| PS Ratio | 15.96 |
| Price to Book Value | 2.543 |
| Price | 14.87 |
| Earnings Yield | -3.00% |